Seres Therapeutics Inc (MCRB)
0.7636
+0.14
(+22.25%)
USD |
NASDAQ |
Apr 23, 16:00
0.7636
0.00 (0.00%)
After-Hours: 18:14
Seres Therapeutics Cash from Operations (TTM): -117.35M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -117.35M |
September 30, 2023 | -122.75M |
June 30, 2023 | -123.07M |
March 31, 2023 | -238.96M |
December 31, 2022 | -228.82M |
September 30, 2022 | -227.79M |
June 30, 2022 | -40.46M |
March 31, 2022 | -30.26M |
December 31, 2021 | 6.688M |
September 30, 2021 | 40.62M |
June 30, 2021 | -112.98M |
March 31, 2021 | -98.86M |
December 31, 2020 | -93.61M |
September 30, 2020 | -89.73M |
June 30, 2020 | -82.16M |
March 31, 2020 | -68.38M |
December 31, 2019 | -76.52M |
September 30, 2019 | -49.81M |
June 30, 2019 | -54.60M |
Date | Value |
---|---|
March 31, 2019 | -68.48M |
December 31, 2018 | -62.85M |
September 30, 2018 | -96.13M |
June 30, 2018 | -76.66M |
March 31, 2018 | -76.64M |
December 31, 2017 | -75.52M |
September 30, 2017 | -75.72M |
June 30, 2017 | -83.48M |
March 31, 2017 | -83.14M |
December 31, 2016 | 43.92M |
September 30, 2016 | 53.16M |
June 30, 2016 | 53.24M |
March 31, 2016 | 68.91M |
December 31, 2015 | -40.84M |
September 30, 2015 | -33.39M |
June 30, 2015 | -24.86M |
March 31, 2015 | -17.28M |
December 31, 2014 | -10.36M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-238.96M
Minimum
Mar 2023
40.62M
Maximum
Sep 2021
-95.20M
Average
-89.73M
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
Integra Lifesciences Holdings Corp | 139.96M |
Nuwellis Inc | -17.94M |
Axogen Inc | -5.716M |
Axsome Therapeutics Inc | -145.08M |
908 Devices Inc | -25.06M |